Mutual of America Capital Management LLC Sells 9,632 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Mutual of America Capital Management LLC lessened its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 73.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,549 shares of the medical instruments supplier’s stock after selling 9,632 shares during the period. Mutual of America Capital Management LLC’s holdings in ICU Medical were worth $354,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the company. FMR LLC boosted its holdings in shares of ICU Medical by 89.9% during the third quarter. FMR LLC now owns 1,124,995 shares of the medical instruments supplier’s stock worth $133,886,000 after acquiring an additional 532,483 shares during the period. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of ICU Medical by 59.2% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 1,015,006 shares of the medical instruments supplier’s stock worth $120,796,000 after acquiring an additional 377,532 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of ICU Medical by 28.1% during the third quarter. Ameriprise Financial Inc. now owns 324,867 shares of the medical instruments supplier’s stock worth $38,662,000 after acquiring an additional 71,258 shares during the period. Nuance Investments LLC boosted its stake in shares of ICU Medical by 45.2% in the third quarter. Nuance Investments LLC now owns 292,670 shares of the medical instruments supplier’s stock valued at $34,831,000 after buying an additional 91,137 shares during the period. Finally, Boston Trust Walden Corp boosted its stake in shares of ICU Medical by 6.2% in the third quarter. Boston Trust Walden Corp now owns 267,494 shares of the medical instruments supplier’s stock valued at $31,834,000 after buying an additional 15,712 shares during the period. Institutional investors own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

Separately, KeyCorp boosted their price target on ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th. One investment analyst has rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $123.00.

ICU Medical Trading Up 1.4 %

Shares of ICUI stock opened at $97.76 on Wednesday. ICU Medical, Inc. has a 1 year low of $78.28 and a 1 year high of $212.43. The stock has a market cap of $2.38 billion, a P/E ratio of -79.48 and a beta of 0.69. The company has a current ratio of 2.53, a quick ratio of 1.06 and a debt-to-equity ratio of 0.74. The stock has a 50 day simple moving average of $102.12 and a 200 day simple moving average of $98.06.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 EPS for the quarter, beating the consensus estimate of $0.85 by $0.39. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. The business had revenue of $587.86 million during the quarter, compared to the consensus estimate of $564.77 million. On average, research analysts predict that ICU Medical, Inc. will post 3.52 earnings per share for the current fiscal year.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $107.19, for a total transaction of $1,458,105.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, VP Daniel Woolson sold 791 shares of the company’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares in the company, valued at $1,373,814.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Christian B. Voigtlander sold 13,603 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $107.19, for a total transaction of $1,458,105.57. The disclosure for this sale can be found here. Insiders sold a total of 24,262 shares of company stock worth $2,545,532 over the last three months. Corporate insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.